TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapy

被引：0
|
作者：
Julia Eckardt
Christopher Schroeder
Peter Martus
Sorin Armeanu-Ebinger
Olga Kelemen
Axel Gschwind
Irina Bonzheim
Thomas Eigentler
Teresa Amaral
Stephan Ossowski
Olaf Rieß
Lukas Flatz
Claus Garbe
Andrea Forschner
机构：
[1] University Hospital of Tübingen,Department of Dermatology
[2] University Hospital Tübingen,Institute for Clinical Epidemiology and Applied Biometrics
[3] University Hospital Tübingen,Institute of Medical Genetics and Applied Genomics
[4] University Hospital Tübingen,Institute of Pathology and Neuropathology
[5] Charité Berlin,Department of Dermatology
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Anti-PD-1; Adjuvant; Melanoma; Checkpoint inhibition; Tumor mutational burden; RFS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：833 / 840
页数：7
相关论文
共 50 条
  • [41] New approach to adjuvant therapy in high-risk melanoma patients.
    Elias, E. George
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Inflammatory and autoimmune predictive markers of response to anti-PD-1/PD-L1 therapy in NSCLC and melanoma
    Musaelyan, Aram A. A.
    Lapin, Sergey L. V.
    Urtenova, Margarita A. A.
    Odintsova, Svetlana V. V.
    Chistyakov, Ivan V. V.
    Ulitin, Andrey M. M.
    Akopov, Andrey L. L.
    Orlov, Sergey V. V.
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2022, 24 (03)
  • [43] Predictive biomarkers for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients
    Subrahmanyam, Priyanka
    Dong, Zhiwan
    Gusenleitner, Daniel
    Giobbie-Hurder, Anita
    Severgnini, Mariano
    Zhou, Jun
    Manos, Michael
    Maecker, Holden
    Hodi, F. Stephen
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [44] Neutrophil subset investigation in stage III melanoma patients undergoing anti-PD-1 immunotherapy or anti-BRAF/MEK target therapy
    Trocchia, Marialuisa
    Cristinziano, Leonardo
    Modestino, Luca
    Ventrici, Annagioia
    Loffredo, Stefania
    Ferrara, Anne Lise
    Tocchetti, Carlo Gabriele
    Troiani, Teresa
    Marone, Gianni
    Galdiero, Maria Rosaria
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1105 - 1105
  • [45] Adjuvant Anti-PD-1 Antibody Therapy for Advanced Melanoma: A Multicentre Study of 78 Japanese Cases
    Muto, Yusuke
    Kambayashi, Yumi
    Kato, Hiroshi
    Fukushima, Satoshi
    Ito, Takamichi
    Maekawa, Takeo
    Fujisawa, Yasuhiro
    Yoshino, Koji
    Uchi, Hiroshi
    Matsushita, Shigeto
    Yamamoto, Yuki
    Amagai, Ryo
    Ohuchi, Kentaro
    Hashimoto, Akira
    Fujimura, Taku
    ACTA DERMATO-VENEREOLOGICA, 2022, 102
  • [46] PROGNOSTIC FACTORS FOR OVERALL SURVIVAL IN PATIENTS WITH ADVANCED MELANOMA TREATED WITH ANTI-PD-1 THERAPY - THE MELIMMUNE SCORE
    Lobo-Martins, Soraia
    Martins-Branco, Diogo
    Semedo, Patricia Miguel
    Alvim, Cecilia Melo
    Monteiro, Ana Maria
    Vendrell, Ines
    Gouveia, Emanuel
    Passos, Maria Jose
    Costa, Luis
    Mansinho, Andre
    de Sousa, Rita Teixeira
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A4 - A4
  • [47] Metabolic factors affecting response to adjuvant anti-PD1 therapy for melanoma
    Bruno, Sabrina
    Knight, Andrew David
    Wang, Hong
    Sander, Cindy
    Karapetyan, Lilit
    Kirkwood, John M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [48] A real-world study of adjuvant anti-PD-1 immunotherapy on stage III melanoma with BRAF, NRAS, and KIT mutations
    Sun, Wei
    Xu, Yu
    Yan, WangJun
    Wang, ChunMeng
    Hu, Tu
    Luo, ZhiGuo
    Zhang, XiaoWei
    Liu, Xin
    Chen, Yong
    CANCER MEDICINE, 2023, 12 (15): : 15945 - 15954
  • [49] Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy
    Jacques, Sarah K.
    McKeown, Janet
    Grover, Piyush
    Johson, Douglas B.
    Zaremba, Anne
    Dimitriou, Florentia
    Weiser, Roi
    Farid, Mohamad
    Namikawa, Kenjiro
    Sullivan, Ryan J.
    Rutkowski, Piotr
    Lebbe, Celeste
    Hamid, Omid
    Zager, Jonathan S.
    Michielin, Olivier
    Neyns, Bart
    Nakamura, Yasuhiro
    Robert, Caroline
    Mehnert, Janice
    Ascierto, Paolo A.
    Bhave, Prachi
    Park, Benjamin
    Zimmer, Lisa
    Mangana, Joanna
    Mooradian, Megan
    Placzke, Joanna
    Allayous, Clare
    Oliva, Isabella C. Glitza
    Mehmi, Inderjit
    Depalo, Danielle
    Wicky, Alexandre
    Schwarze, Julia K.
    Roy, Severine
    Boatwright, Christina
    Vanella, Vito
    Long, Georgina, V
    Menzies, Alexander M.
    Lo, Serigne N.
    Carlino, Matteo S.
    EUROPEAN JOURNAL OF CANCER, 2024, 199
  • [50] Anti-PD-1 Antibody Therapy in renal transplant (Choroid-) Melanoma Patients
    Winkler, J.
    Bender, C.
    Lang, N.
    Zeier, M.
    Enk, A.
    Hassel, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 29 - 30
12345